LOGO
  • About
  • Science
  • Patents
  • Academic Program
  • Blog
  • Industry News
  • e·Meditation
  • English
    • English
    • Русский
    • العربية
    • Deutsch
    • Español
    • Français
    • हिन्दी
    • 日本語
    • 한국어
    • Polski
    • Português
    • 简体中文
  1. Home
  2. blog

Non‑invasive auricular VNS during retrieval boosts recollection for unpleasant images in 75-person study

A University of Potsdam study (N=75) found that non-invasive auricular vagus nerve stimulation during a recognition test selectively increased high-confidence recollection for unpleasant images; overall recognition was unchanged and effects were modest.

25 May 2026

KGMU and IIT Kanpur secure patent for ear-worn vagus nerve stimulator aimed at anxiety and panic

KGMU and IIT Kanpur won a utility patent under the SIB SHInE programme for an ear-worn vagus nerve stimulator aimed at reducing anxiety and managing panic attacks. The device is the third utility patent from SIB SHInE; further patent applications are under examination.

25 May 2026

China reports patient improved from ASIA A to C after combined BCI, spinal stimulation and exoskeleton treatment

Xuanwu Hospital reports a paraplegic patient improved from ASIA A to ASIA C one year after receiving the invasive Beinao No.1 BCI combined with temporally programmed spinal cord stimulation and an exoskeleton. The case, reported by CCTV, describes a single‑patient clinical application performed on May 16, 2025.

23 May 2026

Kordata launches to bring neural recording tech into clinical trial sites

Kordata Dynamics launched from BIOS Health to add neural recording and real‑time dosing tools to hospital trial sites. BIOS retains majority ownership and Emil Hewage will lead the spinout, which targets CNS trials in Alzheimer’s, Parkinson’s and epilepsy.

23 May 2026

Burke Rehab highlights BrainQ trial, Vivistim program and cryoneurolysis during Stroke Awareness Month

Burke Rehabilitation is enrolling patients in the BrainQ EMAGINE trial (NCT06386874), offering an outpatient Vivistim vagus nerve stimulation program, trials of tDCS for aphasia, and cryoneurolysis for spasticity, the hospital’s neurorehabilitation lead said during Stroke Awareness Month.

20 May 2026

Presentation: Intensive, individualized rehab reported to improve function and fatigue in chronic post-stroke disability

A session titled "Intensive Individualized Recovery in Chronic Post-stroke Disability" reported that higher-intensity, personalized rehab produced functional gains and reduced fatigue, and suggested extended neuroplasticity as a mechanism; the source did not provide sample sizes or peer-reviewed results.

20 May 2026

Decoding the Crosstalk Between the Nervous System and Cancer

InteroCANCEption researchers at the Francis Crick Institute report that sensory nerves support tumour growth, that lung tumours remodel nearby nerves, and that cigarette smoke can boost neuronal activity to accelerate tumour progression via a neuro‑immune pathway.

20 May 2026

Organoid intelligence: lab-grown brain tissue explored as low-power computing

Researchers are testing 'organoid intelligence'—computing with lab-grown brain tissue—as a low-power alternative to energy-intensive AI. Early demos (Pong, signal prediction, speech classification) show basic computation, but scalability and performance versus silicon remain unproven.

20 May 2026

Magnetoelectric Backscatter System Improves Wireless Links for Bioelectronic Implants

A 2026 Communications Engineering paper by Alrashdan et al. reports a magnetoelectric backscatter link that reduces implant power use and sustains data transmission through tissue in ex vivo and phantom tests, with ranges from millimetres to several centimetres.

14 May 2026

Frontiers review flags vagus‑targeted neuromodulation as a potential therapy for sepsis‑associated gastrointestinal dysfunction

A 2026 Frontiers in Medicine review frames sepsis‑associated gastrointestinal dysfunction (SAGD) as a neuroimmune and gut–brain disorder and highlights vagus‑targeted neuromodulation, especially taVNS, as a candidate therapy while noting direct clinical evidence is still limited.

14 May 2026

Photobiomodulation: what red‑light therapy does and where the evidence stands

Recent meta‑analyses and reviews support red and near‑infrared photobiomodulation for wound healing, some pain conditions, hair loss and oral mucositis; transcranial uses show early promising signals but lack standardized, long‑term trials.

14 May 2026

BrainPatch.AI Will Participate in the International Symposium “Perspectives of Integrative Neuroscience” at IFBioScFU 2026

BrainPatch.AI will participate in the International Symposium “Perspectives of Integrative Neuroscience” at IFBioScFU 2026 in Almaty on June 3–4, 2026.

14 May 2026

Ultrasound targeted at dorsal ACC produced delayed pain reduction in human study

A Nature Communications study by the University of Plymouth and University of Exeter found low‑intensity transcranial ultrasound to the dorsal anterior cingulate cortex produced a delayed reduction in experimentally induced pain, with altered brain connectivity and biochemical changes observed by MRI/MRS.

14 May 2026

CorTec's Brain Interchange Accepted into FDA TAP; Third U.S. Patient Implanted

CorTec's Brain Interchange™ has been accepted into the FDA's Total Product Life Cycle Advisory Program and received Breakthrough Device Designation; the company reported a third patient implant in the NIH‑funded U.S. clinical study and nine months of stable device operation in the first U.S. participant.

25 Apr 2026

Report: Lucid-dreaming devices market to reach $201.8M by 2033; North America holds 40%

DataM Intelligence projects the lucid-dreaming devices market will grow from $113.1M in 2023 to $201.8M by 2033, with North America holding a 40% share. The report highlights REM-detection and EEG wearables, recent product updates from iWinks and Dreem, and gaps in clinical validation.

25 Apr 2026

Secondary head-to-head comparison: LIFU vs rTMS for motor recovery after stroke

A PLOS One secondary analysis of a randomized trial (n=50) found similar short‑term Fugl–Meyer and Barthel gains after subacute stroke with LIFU or rTMS, while LIFU produced larger change‑from‑baseline motor improvements and increased prefrontal fALFF on fNIRS.

25 Apr 2026
← 1 2 3 4 5 6 7 8 9 10 11 12 →

Search

About Us

Stay updated with the latest events and innovations from BrainPatch.ai by following our news and updates!

Categories

  • Announcements
  • Blog
  • Articles
  • Industry News
  • Science News

Archives

  • January 2022
  • January 2024
  • January 2025
  • January 2026
  • February 2023
  • February 2024
  • February 2026
  • March 2023
  • March 2024
  • March 2026
  • April 2025
  • April 2026
  • May 2020
  • May 2022
  • May 2026
  • June 2019
  • June 2022
  • June 2023
  • June 2025
  • July 2022
  • July 2024
  • July 2025
  • August 2022
  • August 2025
  • September 2020
  • September 2024
  • September 2025
  • October 2019
  • October 2021
  • October 2022
  • October 2024
  • October 2025
  • November 2022
  • December 2021
  • December 2022

🍪 We use cookies

We use cookies to enhance your browsing experience and analyze our traffic. Privacy Policy

BrainPatch® and e·Meditation® is a registered trademarks of BrainPatch Ltd.

Follow Us

Site map

  • Home
  • About
  • News
  • Industry News
  • Companies
  • Science
  • Patents
  • Academic Program
  • e·Meditation Device

Follow Us

  • Facebook
  • Instagram
  • LinkedIn
  • X
  • sales@brainpatch.ai
  •  

Contact Us

  • BrainPatch Limited,
    9 Hills Road, CB2 1GE, Cambridge, United Kingdom
    Company Number 11271285
    VAT GB310938419
  • BrainPatch Limited,
    Landscape House, Baldonnell Business Park, Baldonnell, Dublin, D223PK7, Ireland
    Company Number 678405

© 2026 All rights reserved. Created by: BrainPatch Ltd.

Privacy Policy